FindTrial
Sign In

Clinical observation on efficacy of ulinastatin and antibiotic treatment for severe pneumonia in ICU

Clinical observation on efficacy of ulinastatin and antibiotic treatment for severe pneumonia in ICU

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014694
Enrollment
Unknown
Registered
2018-01-30
Start date
2015-10-01
Completion date
Unknown
Last updated
2018-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe pneumonia

Interventions

control group:conventional treatment based on the use of antimicrobial therapy
Combination group:On the basis of the treatment of the control group, the combination of ulinastatin

Sponsors

Wuxi Huishan District People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients should meet the diagnostic criteria for severe pneumonia developed by the 2007 Infectious Diseases Society / American Thoracic Society. All patients should meet the criteria of ICU admitted to severe pneumonia. All subjects and their families have signed informed consent and obtained the approval of Medical Ethics Committee of Huishan District People's Hospital of Wuxi.

Exclusion criteria

Exclusion criteria: Malignant tumor, connective tissue disease, tuberculosis, pulmonary embolism, hyperthyroidism, immune dysfunction, severe heart, liver, kidney dysfunction, allergic to the study drug.

Design outcomes

Primary

MeasureTime frame
WBC;PCT;CRP;—

Countries

China

Contacts

Public ContactWang Kaicheng

Wuxi Huishan District People's Hospital

wxhsqrmyy@163.com+86 0510-83830976

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026